The Roles of Dopamine Transport Inhibition and Dopamine Release Facilitation in Wake Enhancement and Rebound Hypersomnolence Induced by Dopaminergic Agents

STUDY OBJECTIVE: Rebound hypersomnolence (RHS: increased sleep following increased wake) is a limiting side-effect of many wake-promoting agents. In particular, RHS in the first few hours following wake appears to be associated with dopamine (DA)-releasing agents, e.g., amphetamine, but whether it c...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: Gruner, John A., Marcy, Val R., Lin, Yin-Guo, Bozyczko-Coyne, Donna, Marino, Michael J., Gasior, Maciej
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Associated Professional Sleep Societies, LLC 2009
Pynciau:
Dopamine Agents and Rebound Hypersomnolence
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC2768949/
https://ncbi.nlm.nih.gov/pubmed/19928382
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg